Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing-Reference-Cited by-同舟云学术

Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing

Published:2015-03-30 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Arulanandam Rozanne,Batenchuk Cory,Varette Oliver,Zakaria Chadi,Garcia Vanessa,Forbes Nicole E.,Davis Colin,Krishnan Ramya,Karmacharya Raunak,Cox Julie,Sinha Anisha,Babawy Andrew,Waite Katherine,Weinstein Erica,Falls Theresa,Chen Andrew,Hamill Jeff,De Silva Naomi,Conrad David P.,Atkins Harold,Garson Kenneth,Ilkow Carolina,Kærn Mads,Vanderhyden Barbara,Sonenberg Nahum,Alain Tommy,Le Boeuf Fabrice,Bell John C.,Diallo Jean-Simon

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms7410.pdf

Reference47 articles.

1. Ilkow, C., Swift, S. L., Bell, J. C. & Diallo, J. S. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. PLoS Pathog. 10, e1003836 (2014) .

2. Russell, S. J., Peng, K. W. & Bell, J. C. Oncolytic virotherapy. Nat. Biotechnol. 30, 658–670 (2012) .

3. Breitbach, C. J. et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477, 99–102 (2011) .

4. Heo, J. et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med. 19, 329–336 (2013) .

5. Ottolino-Perry, K., Diallo, J. S., Lichty, B. D., Bell, J. C. & Andrea McCart, J. Intelligent design: combination therapy with oncolytic viruses. Mol. Ther. 18, 251–263 (2009) .

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy;Genes;2024-09-11

2. Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy;Nature Communications;2024-08-23

3. Activation and Evasion of the FEAR Pathway by RNA Viruses;2024-08-22

4. Oncolytic Activity of Sindbis Virus with the Help of GM-CSF in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-06-29

5. Tepilamide Fumarate as a Novel Potentiator of Virus-Based Therapy;Viruses;2024-06-05